BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33607786)

  • 1. COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
    Ding YL; Sun SF; Zhao GL
    Medicine (Baltimore); 2021 Feb; 100(7):e24561. PubMed ID: 33607786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.
    Tan Y; Chen Q; Xing Y; Zhang C; Pan S; An W; Xu H
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
    Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
    J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
    Chen M; Zhu X; Zhang L; Zhao D
    BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in Breast, colorectal and gastric cancers.
    Salimian N; Peymani M; Ghaedi K; Hashemi M; Rahimi E
    Gene; 2024 Jan; 892():147867. PubMed ID: 37783295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
    Zhang J; Dai WJ; Yang XZ
    Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
    Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma.
    Chen HC; Tseng YK; Shu CW; Weng TJ; Liou HH; Yen LM; Hsieh IC; Wang CC; Wu PC; Shiue YL; Fu TY; Tsai KW; Ger LP; Liu PF
    J Oral Pathol Med; 2019 Jul; 48(6):468-476. PubMed ID: 30972812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
    Qi H; Wang Y
    Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric juice piR-1245: A promising prognostic biomarker for gastric cancer.
    Zhou X; Liu J; Meng A; Zhang L; Wang M; Fan H; Peng W; Lu J
    J Clin Lab Anal; 2020 Apr; 34(4):e23131. PubMed ID: 31777102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer.
    Ingenwerth M; Nyirády P; Hadaschik B; Szarvas T; Reis H
    Curr Mol Med; 2022; 22(10):941-949. PubMed ID: 33632097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
    Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
    Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
    Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
    J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data.
    Zeng XT; Liu XP; Liu TZ; Wang XH
    Medicine (Baltimore); 2018 Mar; 97(10):e0091. PubMed ID: 29517678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
    Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
    Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
    Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
    J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.